SCHEMBL6582235

SCHEMBL6582235

CCC1(O)CNCC[N]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10839566 0.74
SCHEMBL9851980 0.73
SCHEMBL2372059 0.71
SCHEMBL194227 0.64
SCHEMBL6988066 0.61
SCHEMBL9169515 0.59
SCHEMBL26665294 0.58
SCHEMBL1991199 0.58
SCHEMBL21515959 0.57 TSHR (0.30)
SCHEMBL1091545 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116600806-A Indazole derivatives 豪夫迈·罗氏有限公司 2023-08-15 CN claimed
CN-116600806-A Indazole derivatives 豪夫迈·罗氏有限公司 2023-08-15 CN disclosed
EP-1401831-A1 INDAZOLE BENZIMIDAZOLE COMPOUNDS AS TYROSINE AND SERINE/THREONINE KINASE INHIBITORS CHIRON CORPORATION (US) 2004-03-31 EP disclosed
WO-2003004488-A1 INDAZOLE BENZIMIDAZOLE COMPOUNDS AS TYROSINE AND SERINE/THREONINE KINASE INHIBITORS CHIRON CORPORATION (US) 2003-01-16 WO disclosed